Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 111 (2) , 172-183
Abstract
No abstract availableKeywords
Funding Information
- NIH (RNS065808A, 1S10 RR16798)
- NIH-NIMH (1R03MH098689)
- NIH-NINDS (1R01NS079655)
- National MPS Society
- Genzyme-Sanofi Corp.
- Shire HGT
- Biomarin Pharm. Corp.
- Protalix Biotherapeutics
This publication has 52 references indexed in Scilit:
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1Nature, 2011
- A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effectsNature, 2011
- Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe diseaseJournal of Neuroscience Research, 2010
- Selective Extraction and Effective Separation of Galactosylsphingosine (Psychosine) and Glucosylsphingosine from Other Glycosphingolipids in Pathological Tissue SamplesNeurochemical Research, 2010
- Molecular insights into amyloid regulation by membrane cholesterol and sphingolipids: common mechanisms in neurodegenerative diseasesExpert Reviews in Molecular Medicine, 2010
- A rapid and quantitative LC-MS/MS method to profile sphingolipidsJournal of Lipid Research, 2010
- Common and Uncommon Pathogenic Cascades in Lysosomal Storage DiseasesJournal of Biological Chemistry, 2010
- Regulation Mechanisms and Signaling Pathways of AutophagyAnnual Review of Genetics, 2009
- Newborn Screening for Krabbe Disease: the New York State ModelPediatric Neurology, 2009
- Mitochondrial dynamics and apoptosisGenes & Development, 2008